Jun Fu
- Cancer Research top 10%
- MicroRNA in disease regulation 5
- Cancer, Hypoxia, and Metabolism 3
- Otorhinolaryngology top 10%
- Head and Neck Cancer Studies 3
-
- Glioma Diagnosis and Treatment 6
-
- RNA modifications and cancer 3
- Rehabilitation top 10%
-
- Genital Health and Disease 4
-
- Ferroptosis and cancer prognosis 3
-
- Peptidase Inhibition and Analysis 3
- Co-authors
- Liangfang ShenYiwei LiaoYong GuoZhanzhan LiRenjun PengLei ChengHaiting ZhaoQing Liu
In The Last Decade
Jun Fu
43 papers receiving 761 citations
Peers
Comparison fields: 5 of 74
- Cancer Research 291
- Otorhinolaryngology 38
- Genetics 61
- Molecular Biology 392
- Rehabilitation 35
Countries citing papers authored by Jun Fu
This map shows the geographic impact of Jun Fu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jun Fu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jun Fu more than expected).
Fields of papers citing papers by Jun Fu
This network shows the impact of papers produced by Jun Fu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jun Fu. The network helps show where Jun Fu may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Jun Fu, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2024 | 3 | |
| 3 | 2022 | 14 | |
| 4 | 2019 | 8 | |
| 5 | 2019 | 13 | |
| 6 | 2019 | 15 | |
| 7 | 2019 | 25 | |
| 8 | 2018 | 7 | |
| 9 | 2018 | 17 | |
| 10 | 2018 | 27 | |
| 11 | 2017 | 146 | |
| 12 | 2016 | 1 | |
| 13 | 2016 | 35 | |
| 14 | 2015 | 29 | |
| 15 | 2014 | 15 | |
| 16 | 2012 | 23 | |
| 17 | 2012 | 7 | |
| 18 | Overexpression of MAGE-D4 in colorectal cancer is a potentially prognostic biomarker and immunotherapy target. | 2006 | 18 |
| 19 | LOCAL INJECTION OF AiDi FOR MALIGNANT PLEURAL EFFUSION | 2005 | 2 |
| 20 | 2003 | 2 |
About Jun Fu
Jun Fu is a scholar working on Cancer Research, Otorhinolaryngology, Genetics, Oncology and Pulmonary and Respiratory Medicine, having authored 44 papers that have together received 767 indexed citations. Recurring topics across this work include Glioma Diagnosis and Treatment (6 papers), MicroRNA in disease regulation (5 papers), Genital Health and Disease (4 papers), Ferroptosis and cancer prognosis (3 papers), Peptidase Inhibition and Analysis (3 papers), Cancer, Hypoxia, and Metabolism (3 papers), RNA modifications and cancer (3 papers) and Head and Neck Cancer Studies (3 papers). The work is most often cited by research in Cancer Research (291 citations), Otorhinolaryngology (38 citations), Genetics (61 citations), Molecular Biology (392 citations) and Rehabilitation (35 citations). Jun Fu has collaborated with scholars based in China, Hong Kong and Taiwan. Frequent co-authors include Liangfang Shen, Liangfang Shen, Yiwei Liao, Yong Guo, Zhanzhan Li, Renjun Peng, Lei Cheng, Haiting Zhao, Qing Liu and Yanyan Li. Their work appears in journals such as Oncotarget, OncoTargets and Therapy, Bioscience Reports, Cancer Management and Research and Frontiers in Oncology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.